Discovery: Leverage Intelligence
Quickly solving a problem. Using real-life health related data to inform strategy. Shift from planning assumptions to real-life intelligence – powered by behavior, sentiment and engagement data.
Inside the GLP-1 Conversation: A 30 Minute Q&A on the Consumer Journey
Inside This Session
Explore the latest insights from the GLP-1 conversation, from dose adjustments and weight loss plateaus to discontinuation and the branded vs compounded debate. In this 30-minute Q&A, Talking Medicines DrugVoice shares real-life Consumer intelligence shaping obesity and metabolic health, and what they mean for Pharma and Medical Communications strategy.
More from The Talking Room
Large Language Models and Regulatory-Grade GLP-1 Content: Challenges and the Need for Accurate Message Measurement
Can large language models truly support regulatory-grade pharmaceutical communication? Learn more in our recent TMLabs briefing session.
Introducing DrugVoice
DrugVoice turns unstructured HCP data into Predictive HCP Intelligence, revealing how scientific messaging lands and influences HCP behavior.